日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Encouraging response rates and high mobilization success with brentuximab vedotin plus GDP in adult relapsed/refractory classical Hodgkin lymphoma: A real-world study

在成人复发/难治性经典型霍奇金淋巴瘤中,使用布伦妥昔单抗联合GDP治疗可获得令人鼓舞的缓解率和较高的动员成功率:一项真实世界研究

Namdaroğlu, Sinem; Batgi, Hikmetullah; Kakcı, Merve; Öztürk, Osman Can; Şeker, Ömer; Güzel, Berna; Tayfur, Kardelen; Başcı, Semih

Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations

对携带 WT1、FLT3 或 NPM 基因突变的急性髓系白血病患者化疗前白细胞、血小板、单核细胞、血红蛋白和平均血小板体积水平进行分析

Merdin, Alparslan; Dal, Mehmet Sinan; Çakar, Merih Kizil; Yildiz, Jale; Ulu, Bahar Uncu; Batgi, Hikmetullah; Tetik, Ayşegül; Seçilmiş, Sema; Darçin, Tahir; Şahin, Derya; Bakirtaş, Mehmet; Başçi, Semih; Yiğenoğlu, Tuğçe Nur; Baysal, Nuran Ahu; İskender, Dicle; Altuntaş, Fevzi

Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting

造血干细胞移植背景下发热性中性粒细胞减少症的风险适应性管理和早期停止经验性抗生素治疗

Kaya, Ali Hakan; Tekgündüz, Emre; Duygu, Fazilet; Koca, Dicle; Bekdemir, Filiz; Batgi, Hikmetullah; Ulu Uncu, Bahar; Yiğenoğlu, Tuğçe Nur; Dal, Mehmet Sinan; Çakar Kızıl, Merih; Altuntaş, Fevzi

A 80-Year-Old Woman with B-Cell Prolymphocytic Leukemia

一名80岁患有B细胞前淋巴细胞白血病的女性

Merdin, Alparslan; Yıldız, Jale; Dal Mehmet, Sinan; Çakar, Merih Kızıl; Batgi, Hikmetullah; Tekgündüz, Emre; Onursever, Aykut; Altuntaş, Fevzi

BK Virus-associated Hemorrhagic Cystitis in Patients with Allogeneic Hematopoietic Cell Transplantation: Report of Three Cases

异基因造血干细胞移植患者BK病毒相关性出血性膀胱炎:三例报告

Mert, Duygu; Batgi, Hikmetullah; Merdin, Alparslan; Çeken, Sabahat; Dal, Mehmet Sinan; Tekgündüz, Emre; Altuntaş, Fevzi; Ertek, Mustafa